JAZZ FY 2008 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$68M+3.4% YoY

Gross Profit

$54M79.4% margin

Operating Income

-$170M-252.3% margin

Net Income

-$184M-273.0% margin

EPS (Diluted)

$-7.19

Cash Flow

Operating Cash Flow

-$130M

Free Cash Flow

-$159M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$117M

Total Liabilities

$210M

Stockholders' Equity

-$93M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$65M	+3.4%
Gross Profit	$54M	$56M	-5.0%
Operating Income	-$170M	-$139M	-22.8%
Net Income	-$184M	-$139M	-32.8%